A retrospective study to determine a weight-based and anti-Xa-guided enoxaparin dosing protocol in intensive care unit trauma patients and its clinical VTE rates
Latest Information Update: 15 Oct 2021
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Therapeutic Use
- 15 Oct 2021 New trial record
- 01 Sep 2021 Primary endpoint has not been met (Incidence of clinical VTE ; was classified as either deep vein thrombosis or pulmonary embolism) , according to Results published in the Journal of Surgical Research
- 01 Sep 2021 Results published in the Journal of Surgical Research